Growing community of inventors

Saitama, Japan

Yoshinobu Hashizume

Average Co-Inventor Count = 6.67

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Yoshinobu HashizumeYasuko Koda (2 patents)Yoshinobu HashizumeKohei Miyazono (1 patent)Yoshinobu HashizumeAkiko Tanaka (1 patent)Yoshinobu HashizumeHirofumi Yamamoto (1 patent)Yoshinobu HashizumeFumihiko Ishikawa (1 patent)Yoshinobu HashizumeYoriko Saito (1 patent)Yoshinobu HashizumeHitomi Yuki (1 patent)Yoshinobu HashizumeHirokazu Kubota (1 patent)Yoshinobu HashizumeHiroo Koyama (1 patent)Yoshinobu HashizumeTomonori Taguri (1 patent)Yoshinobu HashizumeKatsuhiko Sekimata (1 patent)Yoshinobu HashizumeTomohiro Sato (1 patent)Yoshinobu HashizumeKohei Miyazono (0 patent)Yoshinobu HashizumeYoshinobu Hashizume (2 patents)Yasuko KodaYasuko Koda (2 patents)Kohei MiyazonoKohei Miyazono (29 patents)Akiko TanakaAkiko Tanaka (21 patents)Hirofumi YamamotoHirofumi Yamamoto (6 patents)Fumihiko IshikawaFumihiko Ishikawa (3 patents)Yoriko SaitoYoriko Saito (3 patents)Hitomi YukiHitomi Yuki (2 patents)Hirokazu KubotaHirokazu Kubota (1 patent)Hiroo KoyamaHiroo Koyama (1 patent)Tomonori TaguriTomonori Taguri (1 patent)Katsuhiko SekimataKatsuhiko Sekimata (1 patent)Tomohiro SatoTomohiro Sato (1 patent)Kohei MiyazonoKohei Miyazono (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Riken Corporation (2 from 854 patents)

2. The University of Tokyo (1 from 1,282 patents)


2 patents:

1. 10954216 - BMP-signal-inhibiting compound

2. 9604988 - Agent for treating or inhibiting recurrence of acute myeloid leukemia

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/19/2025
Loading…